title: Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
abstract: Pyrrolizidine alkaloid-containing plants are widespread in the world and may be the most common poisonous plants affecting livestock, wildlife, and humans. Pyrrolizidine alkaloids require metabolism to exert their genotoxicity and tumorigenicity. Our mechanistic studies have determined that metabolism of the retronecine-type (riddelliine, retrorsine, and monocrotaline), heliotridine-type (lasiocarpine), and otonecine-type (clivorine) tumorigenic pyrrolizidine alkaloids in vivo and/or in vitro all generates a common set of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP)-derived DNA adducts responsible for tumor induction. All the pyrrolizidine alkaloids studied previously are diesters with an ester linkage at the C7 and C9 positions of the necine base. In this study, we report that F344 rat liver microsomal metabolism of heliotrine, a tumorigenic monoester bearing a hydroxyl group at the C7 of the necine base, resulted in the formation of the dehydroheliotridine (DHH) metabolite. When incubations of heliotrine were carried out in the presence of calf thymus DNA, the same set of DHP-derived DNA adducts was formed. These results support that DHP-derived DNA adducts are potential common biomarkers of pyrrolizidine alkaloid exposure and tumorigenicity. For comparison, the dehydroretronecine (DHR)-derived DNA adducts formed from metabolism of riddleiine, retrorsine, monocrotaline, riddelleiine N-oxide, and retrorsine N-oxide were measured in parallel; the levels of DHP-derived DNA adduct formation were in the order: riddelliine approximately retrorsine>monocrotaline>retrorsine N-oxide>or=riddelliine N-oxide>heliotrine.
authors.affiliation: National Center for Toxicological Research, Jefferson, AR 72079, United States.
authors.forename: Qingsu
authors.initials: Q
authors.lastname: Xia
authors.forename: Jian
authors.initials: J
authors.lastname: Yan
authors.forename: Ming W
authors.initials: MW
authors.lastname: Chou
authors.forename: Peter P
authors.initials: PP
authors.lastname: Fu
mesh_terms: D000818:Animals; D015415:Biomarkers; D001711:Biotransformation / Q000187:drug effects; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D002942:Circular Dichroism; D004247:DNA / Q000494:pharmacology; D018736:DNA Adducts / Q000187:drug effects*; D066298:In Vitro Techniques; D007553:Isotope Labeling; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D016686:Monocrotaline / Q000031:analogs & derivatives* / Q000378:metabolism / Q000633:toxicity; D011763:Pyrrolizidine Alkaloids / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D013237:Stereoisomerism; D013950:Thymus Gland / Q000737:chemistry
chemical_list: D015415:Biomarkers; D018736:DNA Adducts; D011763:Pyrrolizidine Alkaloids; C013672:riddelliine; D016686:Monocrotaline; D004247:DNA; C007241:dehydroretronecine; C003300:retrorsine; C010178:heliotrine